PNOC019: Neoadjuvant Checkpoint Inhibition in Recurrent or Progressive HGG - Clinical Trial
¿Quién puede participar en el Estudio?
Grupo etario
Adults, Children
Detalles del Estudio
Título Completo
A Randomized, Double-Blinded, Pilot Trial of Neoadjuvant Checkpoint Inhibition followed by Combination Adjuvant Checkpoint Inhibition in Children and Young Adults with Recurrent or Progressive High Grade Glioma (HGG)
Investigador Principal
Especialista en neuro-oncología
Número de Protocolo
IRB:
PRO00109073
NCT:
NCT04323046
Fase
Phase
Pilot
ClinicalTrials.gov
View on ClinicalTrials.gov
Estado de inscripción
Abierto para inscripción
Participate
Call 919-684-5301